Clearance Summary
Phadia Prime received FDA 510(k) clearance under submission number K151029, sponsored by Phadia AB. The device was reviewed via the Special premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2016-01-19.
- Submission: K151029
- Applicant / Sponsor: Phadia AB
- Clearance pathway: Special
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5750
- Decision date: 2016-01-19
Classification & Regulation
This clearance is catalogued under FDA product code DHB and 21 CFR 866.5750, within the Immunology review panel as a Class II device.